(Q44500351)

3 December 2017

title

Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients (English)

1 reference

systemic lupus erythematosus

3 December 2017

main subject

1 reference

1

Thelma L Skare

1 reference

3 December 2017

2

Renato Nisihara

1 reference

3 December 2017

5

Shirley Utiyama

1 reference

3 December 2017

author name string

Bruno Bandolin Barbosa

series ordinal

3

1 reference

3 December 2017

Alvaro da Luz

series ordinal

4

1 reference

3 December 2017

Vanessa Picceli

series ordinal

6

1 reference

3 December 2017

publication date

15 February 2013

1 reference

3 December 2017

published in

Clinical Rheumatology

1 reference

3 December 2017

volume

32

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

1065-1070

1 reference

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Anti-cyclic citrullinated peptide antibodies in scleroderma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Anti-Ro/SSA and La/SSB antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Clinical significance of anti-Ro antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2213-7

Anticyclic citrullinated peptide autoantibodies in systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus

1 reference

12 December 2020

Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease

1 reference

12 December 2020

Sjögren's syndrome. Controversies and progress

1 reference

12 December 2020

Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis

1 reference

12 December 2020

Studies of antinuclear antibodies in rheumatoid arthritis

1 reference

12 December 2020

Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

1 reference

12 December 2020

Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen

1 reference

12 December 2020

Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature

1 reference

12 December 2020

Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.

1 reference

12 December 2020

Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations

1 reference

12 December 2020

1 reference

12 December 2020

Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy

1 reference

12 December 2020

HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis

1 reference

12 December 2020

10.1007/S10067-013-2213-7

Identifiers

DOI

1 reference

3 December 2017

1 reference